Craniopharyngioma presenting with severe hyponatremia, hyponatremia-induced myopathy, and panhypopituitarism: a case report by M. D. S. A. Dilrukshi et al.
CASE REPORT Open Access
Craniopharyngioma presenting with severe
hyponatremia, hyponatremia-induced
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Abstract
Background: Craniopharyngiomas are rare intracranial tumors commonly presenting with neurological symptoms.
Reports of severe hyponatremia as a presenting manifestation of a craniopharyngioma and hyponatremia-induced
myopathy are rare. We report the case of a patient with craniopharyngioma presenting with severe hyponatremia,
panhypopituitarism, and hyponatremia-induced myopathy.
Case presentation: A 52-year-old Sri Lankan man presented with anorexia, nausea, fatigue, generalized muscle
weakness, and cramps for 1 week. The onset of his illness had been preceded by vomiting and diarrhea for 1 day
which he attributed to food poisoning. On examination, he had an apathetic disposition with a generalized “sallow
complexion.” He was not dehydrated. Apart from reduced muscle power (4/5) and hyporeflexia, the neurological
examination was normal. His serum sodium was 102 mmol/l; potassium 4.1 mmol/l; chloride 63 mmol/l; plasma
osmolality 272 mosm/KgH2O; urine osmolality 642 mosm/KgH2O; and urine sodium 79 mmol/l. His creatine
phosphokinase was 12,400 U/l, lactate dehydrogenase 628 U/l, aspartate aminotransferase 360 U/l, and alanine
aminotransferase 64 U/l. His hormone profile revealed panhypopituitarism. An electromyogram showed nonspecific
abnormalities while a muscle biopsy did not show any pathology. Magnetic resonance imaging of his brain
demonstrated a well-defined craniopharyngioma with suprasellar extension. His pituitary gland was compressed
and the pituitary stalk was displaced by the tumor. He had marked improvement in muscle power and rapid
reduction of serum creatine phosphokinase levels paralleling the correction of severe hyponatremia, even before
the initiation of hormone replacement.
Conclusions: This case illustrates the rare presentation of severe hyponatremia and hyponatremia-induced myopathy in
patients with craniopharyngioma, awareness of which would facilitate early appropriate investigations and treatment.
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Background
Craniopharyngiomas are rare, solid, or solid-mixed tu-
mors that arise from remnants of the Rathke pouch along
a line from the nasopharynx to the diencephalon [1]. They
are slow growing tumors which clinically manifest only
after the tumor grows to a size of around 3 cm or more.
The majority of patients (75 %) have been reported to
present with neurological symptoms [2], with headache
being the commonest (82 %). Symptoms of endocrine
dysfunction are also common (66 to 90 %) presenting
manifestations [2], but symptomatic severe hyponatre-
mia as a presenting symptom is rare [3–5]. Reports of
hyponatremia-induced myopathy, which is a recognized
non-neurological manifestation of severe hyponatremia
caused by skeletal muscle disruption, are sparse [6–9]. We
report the case of a patient with a craniopharyngioma pre-
senting with severe hyponatremia, panhypopituitarism,
and hyponatremia-induced myopathy.* Correspondence: dilrukmatharage@gmail.com
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Case presentation
A 52-year-old previously healthy Sri Lankan man pre-
sented with anorexia, nausea, fatigue, generalized
muscle weakness, and cramps for 1 week. The onset of
his illness had been preceded by a day of vomiting and
diarrhea which he attributed to food poisoning. On
admission he had constipation, moderate frontal head-
ache, and generalized body weakness but did not report
abdominal pain, fever, cough, or history of polyuria and
increased thirst.
On examination, he had an apathetic disposition with
a generalized “sallow complexion.” He was not dehy-
drated. Apart from reduced muscle power (4/5) and
hyporeflexia, the neurological examination was normal.
His pulse rate was 68 beats per minute and his blood
pressure was 120/80 mmHg. The rest of the physical
examination was normal.
His serum sodium was 102 mmol/l (135 to 145 mmol/l);
potassium 4.1 mmol/l (3.5 to 5 mmol/l); chloride 63
mmol/l (98 to 108 mmol/l); plasma osmolality 272 mosm/
KgH2O (275 to 295 mosm/KgH2O); urine osmolality 642
mosm/KgH2O (300 to 900 mosm/KgH2O); and urine so-
dium 79 mmol/l (40 to 220 mmol/l). His serum calcium
was 7.7 mg/dl (normal 8.5 to 10.5 mg/dl); phosphate 2.6
mmol/l (0.8 to 1.5 mmol/l); creatine kinase 12,400 U/l
(normal up to 25 to 174 U/l); lactate dehydrogenase (LDH)
628 U/l (normal up to 140 to 280 U/l); aspartate amino-
transferase (AST) 360 U/l (normal up to 10 to 35 U/l); and
alanine aminotransferase (ALT) 64 U/l (normal up to 10 to
40 U/l). His hormone profile revealed a serum prolactin of
234 mU/l (normal up to 340 mU/l); luteinizing hormone
(LH) 0.6 U/L (normal 1 to 10 U/L); follicle-stimulating hor-
mone (FSH) 1.1 U/l (normal 1 to 7 U/L); total testosterone
31.1 ng/dl (normal 241 to 827 ng/dl); thyroid-stimulating
hormone (TSH) 0.62 mIU/l (normal 0.55 to 4.7 mIU/l);
free thyroid hormone (FT4) 0.46 ng/dl (normal 0.89 to 1.76
ng/dl), 9 a.m. serum cortisol 69.18 nmol/l (normal 118.6 to
618 nmol/l), and an inadequate response to the short
Synacthen test.
His hemoglobin concentration, leukocyte count, and
platelet count were within normal limits. His erythrocyte
sedimentation rate was 30 mm/hour while his C-reactive
protein was 8.2 mg/l (normal up to 6). His urine analysis
was normal. An ultrasound scan of his abdomen and a
chest radiograph were normal. An electromyogram
showed nonspecific abnormalities while a muscle biopsy
did not show any pathology. Magnetic resonance
imaging of his brain demonstrated a well-defined cranio-
pharyngioma within his pituitary fossa measuring
1.3×1.6×1.6 cm with evidence of suprasellar extension
(Fig. 1). His pituitary gland was compressed and the pi-
tuitary stalk was displaced by the tumor.
He was treated with 3 % saline during the acute phase,
which led to a marked improvement in his muscle
power and rapid reduction of his serum creatine phos-
phokinase (CPK) levels, which paralleled the correction
of severe hyponatremia over 2 to 3 days. Despite his
euvolemic hyponatremic state, we did not restrict his
fluid intake because of the risk of rhabdomyolysis-
induced acute kidney injury given that he had markedly
elevated serum CPK. Furthermore, the diagnosis of pan-
hypopituitarism was delayed because this possibility was
not initially suspected and was compounded by the delay
in obtaining confirmatory hormonal tests which are not
routinely done in our hospital. Once the diagnosis of
panhypopituitarism was established, hormone replace-
ment therapy was commenced with oral hydrocortisone
followed by thyroxine after an interval of 1 week.
Discussion
Our patient had an inadequate TSH increment in re-
sponse to very low FT4 levels (suggestive of secondary
hypothyroidism) associated with very low levels of FSH,
LH, and testosterone levels (suggestive of secondary
hypogonadism). In the context of absence of hyperpig-
mentation typically seen in primary hypoadrenalism due
to elevated serum adrenocorticotropic hormone (ACTH)
levels and absence of severe hyperkalemia typical of
mineralocorticoid deficiency, his inadequate response to
the short Synacthen test was considered to be due to
secondary hypoadrenalism. The panhypopituitarism state
in our patient occurred due to the compression of his
pituitary gland by the tumor.
Severe hyponatremia is defined as a serum sodium
level <120 mmol/L, which may lead to fatal neurological
and non-neurological complications [10]. Our patient
had hypotonic hyponatremia, with high urine osmolality
and high urine sodium excretion. He was euvolemic and
there was no clinical or laboratory evidence of renal,
liver, or heart failure nor history suggestive of diuretic
abuse. Hypopituitarism was thought to cause hyponatre-
mia in our patient. Although hyponatremia is known to
occur in patients with hypopituitarism, severe hypona-
tremia of the degree seen in our patient occurring as a
presenting feature of hypopituitarism is rare [11], indi-
cating an additional contributory factor. Local tumors in
the region of the pituitary, such as craniopharyngiomas,
can cause mechanical compression of the pituitary stalk
leading to an excessive or inappropriate secretion of
antidiuretic hormone (SIADH) due to interruption of
the inhibitory system. There are few reports of patients
with SIADH with pituitary tumors and normal pituitary
functions, where local mechanical stress is a plausible
cause of SIADH [12]. SIADH can cause severe hypona-
tremia. However, other possible causes of SIADH, such
as other malignancies elsewhere, pulmonary disease,
drugs, and central nervous system infections were ex-
cluded by relevant history, laboratory investigations, and
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relevant imaging studies. Since adrenal insufficiency and
hypothyroidism biochemically can mimic SIADH [13], early
accurate diagnosis of a tumor in the pituitary region or a
craniopharyngioma depends upon a high level of clinical
suspicion of a suprasellar lesion and early brain imaging.
Thus far, there have been only few cases of
hyponatremia-induced myopathy reported [6–9] and no re-
port describes its occurrence in the presence of a cranio-
pharyngioma. Our patient who was diagnosed as having a
craniopharyngioma presented with generalized muscle
weakness and elevated muscle enzymes (CPK, LDH, and
AST) associated with severe hyponatremia, which was sug-
gestive of rhabdomyolysis. His low serum calcium and high
serum phosphate levels were consistent with rhabdomyoly-
sis and, therefore, an alternative cause such as vitamin D
deficiency was not considered. His elevated serum AST
was also thought to be due to rhabdomyolysis rather than
coming from the liver since it gradually normalized with
the correction of hyponatremia. Furthermore, there was no
clinical or radiological evidence of liver injury. Other causes
of myopathies such as inflammatory, paraneoplastic, infec-
tious, drugs induced, and toxin induced, and other meta-
bolic causes were excluded in our patient by detailed
history, examination, biochemical investigations, and histo-
pathological investigations relevant to the clinical context.
A marked improvement in his muscle power and rapid re-
duction of serum CPK levels paralleling the correction of
severe hyponatremia, even before initiating steroid and
other hormone replacement, supports the diagnosis of
hyponatremia-induced myopathy in our patient.
There is no established hypothesis to explain the
pathophysiology of hyponatremia-induced myopathy.
One theory is that a reduced extracellular sodium level
may disturb the cell membrane sodium-calcium pumps,
which leads to increased intracellular calcium and acti-
vation of cellular protease and lipase causing rhabdo-
myolysis. Another theory is that in acute hyponatremia,
due to lower osmolality of extracellular fluid, cells start
to swell and in order to maintain cell membrane integ-
rity, intracellular potassium is extruded for hours, which
in turn lowers the transmembrane potential. If the hypo-
natremia state is not corrected, the stressed cells release
creatine kinase and myoglobin with cell injury [6, 7, 14].
The serum creatine kinase may elevate after 48 to 96
hours of hyponatremia either due to the lowered sodium
level itself or the rapid correction of hyponatremia [15].
Conclusions
Severe hyponatremia can be a rare presenting feature of
a craniopharyngioma. A high level of clinical suspicion
Fig. 1 T1-weighted contrast-enhanced magnetic resonance imaging of the brain demonstrates a well-defined craniopharyngioma (arrow) within
the pituitary fossa with suprasellar extension. The pituitary gland is compressed and the pituitary stalk is displaced by the tumor
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and early brain imaging may be helpful in managing pa-
tients with severe hyponatremia accurately. Myopathy is
a rare complication of severe hyponatremia, which war-
rants early recognition and treatment to prevent rhabdo-
myolysis and acute kidney injury.
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